• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2008 Blue Cross Blue Shield Association (BCBS) Radiofrequency catheter ablation of the pulmonary veins for treatment of atrial fibrillation
2008 NIHR Health Technology Assessment programme Rapid systematic review of the impact of participation in research
2008 The Swedish Council on Health Technology Assessment (SBU) Moderately elevated blood pressure
2008 Health Information and Quality Authority (HIQA) The role of human papillomavirus vaccines in reducing the risk of cervical cancer in Ireland
2008 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for metastatic gastric cancer - first line in combination with capecitabine and cisplatin
2008 NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin for moderate to severe plaque psoriasis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Oxabact for primary hyperoxaluria
2008 NIHR Horizon Scanning Centre (NIHR HSC) Telcagepant for acute migraine
2008 NIHR Horizon Scanning Centre (NIHR HSC) Dirucotide for secondary progressive multiple sclerosis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (HuMax-CD20) in combination with methotrexate for rheumatoid arthritis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Aripiprazole (Abilify) for schizophrenia in children and adolescents
2008 NIHR Horizon Scanning Centre (NIHR HSC) Aripiprazole (Abilify) for children and adolescents with bipolar disorder
2008 NIHR Horizon Scanning Centre (NIHR HSC) Canakinumab for cryopyrin associated periodic syndrome
2008 NIHR Horizon Scanning Centre (NIHR HSC) Prucalopride (Resolor) for chronic constipation
2008 NIHR Horizon Scanning Centre (NIHR HSC) AVE0010 (ZP10) for type 2 diabetes mellitus
2008 NIHR Horizon Scanning Centre (NIHR HSC) Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children
2008 NIHR Horizon Scanning Centre (NIHR HSC) Exenatide once-weekly for type 2 diabetes mellitus - second or third line
2008 NIHR Horizon Scanning Centre (NIHR HSC) Alteplase (Activase) for the early (up to 4.5 hours) treatment of acute ischaemic stroke
2008 NIHR Horizon Scanning Centre (NIHR HSC) Ezetimibe (Ezetrol) for hypercholesterolaemia in adolescents
2008 NIHR Horizon Scanning Centre (NIHR HSC) Picoplatin for small cell lung cancer - second line
2008 NIHR Horizon Scanning Centre (NIHR HSC) Decitabine for acute myeloid leukaemia
2008 NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (AMG162) for prevention of bone metastases in prostate cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) BIBW 2992 (Tovok) for advanced or metastatic non-small cell lung cancer after failure of at least one reversible EGFR inhibitor
2008 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) in combination with docetaxel for metastatic breast cancer - first line
2008 NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) for non small cell lung cancer advanced or metastatic-maintenance monotherapy
2008 NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (AMG162) for the prevention of therapy-induced bone loss in non-metastatic breast and prostate cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (AMG 162) for bone metastases from solid tumours and multiple myeloma
2008 NIHR Horizon Scanning Centre (NIHR HSC) Amrubicin for small cell lung cancer - relapsed and/or refractory, extensive disease
2008 NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin (LX-211) for non-infectious uveitis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Rolofylline for acute heart failure
2008 NIHR Horizon Scanning Centre (NIHR HSC) Lorcaserin hydrochloride (APD-356) for obesity or overweight people with at least one co-morbidity
2008 NIHR Horizon Scanning Centre (NIHR HSC) Irbesartan (Aprovel) for heart failure with preserved systolic function
2008 NIHR Horizon Scanning Centre (NIHR HSC) Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation
2008 NIHR Horizon Scanning Centre (NIHR HSC) Imatinib (Glivec) for adjuvant therapy in gastrointestinal stromal tumours
2008 NIHR Horizon Scanning Centre (NIHR HSC) Idrabiotaparinux for the treatment of DVT and/or PE and secondary prevention of venous thromboembolism
2008 NIHR Horizon Scanning Centre (NIHR HSC) Glatiramer acetate (Copaxone) for a single demyelinating event with an active inflammatory process
2008 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Certican) for prophylaxis of organ rejection in renal or cardiac transplantation
2008 NIHR Horizon Scanning Centre (NIHR HSC) Entecavir (Baraclude) for chronic hepatitis B with associated decompensated liver disease
2008 NIHR Horizon Scanning Centre (NIHR HSC) Ecallantide (DX-88) for acquired angioedema
2008 NIHR Horizon Scanning Centre (NIHR HSC) DCVax-Brain for glioblastoma multiforme - newly diagnosed
2008 NIHR Horizon Scanning Centre (NIHR HSC) Dabigatran etexilate (Pradaxa) for stroke prevention in atrial fibrillation
2008 NIHR Horizon Scanning Centre (NIHR HSC) Dabigatran etexilate (Pradaxa) for acute symptomatic venous thromboembolism
2008 NIHR Horizon Scanning Centre (NIHR HSC) Clopidogrel (Plavix) in combination with aspirin for prevention of vascular events in patients with atrial fibrillation
2008 NIHR Horizon Scanning Centre (NIHR HSC) Clevudine (Levovir) for hepatitis B
2008 NIHR Horizon Scanning Centre (NIHR HSC) ChondroCelect for knee cartilage defects
2008 NIHR Horizon Scanning Centre (NIHR HSC) Bortezomib for relapsed and/or refractory follicular non-Hodgkins lymphoma
2008 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for glioblastoma multiforme - relapsed
2008 NIHR Horizon Scanning Centre (NIHR HSC) Belatacept for prophylaxis of organ rejection in renal transplantation
2008 NIHR Horizon Scanning Centre (NIHR HSC) AVE-5026 for the prevention of venous thromboembolism in patients at risk
2008 NIHR Horizon Scanning Centre (NIHR HSC) Apixaban for prevention of venous thromboembolism after joint replacement or with acute medical illness
2008 NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (AZD6140) for acute coronary syndrome
2008 NIHR Horizon Scanning Centre (NIHR HSC) Panitumumab (Vectibix) for first-line metastatic colorectal cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) Nilotinib (Tasigna) for gastrointestinal stromal tumours
2008 NIHR Horizon Scanning Centre (NIHR HSC) Nilotinib (Tasigna) for chronic myeloid leukaemia
2008 NIHR Horizon Scanning Centre (NIHR HSC) Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Mepolizumab (Bosatria) for hypereosinophilic syndrome - first line in combination with corticosteroids
2008 NIHR Horizon Scanning Centre (NIHR HSC) Icatibant (Firazyr) for acute hereditary angioedema
2008 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (RAD-001) for advanced gastroenteropancreatic neuroendocrine tumours
2008 NIHR Horizon Scanning Centre (NIHR HSC) Oral and inhaled treprostinil for pulmonary arterial hypertension: NYHA class III
2008 NIHR Horizon Scanning Centre (NIHR HSC) Transient elastography (FibroScan) for evaluating liver fibrosis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Taranabant (MK-0364) for obesity
2008 NIHR Horizon Scanning Centre (NIHR HSC) Saxagliptin (BMS 477118) for type 2 diabetes
2008 NIHR Horizon Scanning Centre (NIHR HSC) Saredutant (SR-48968) for depression and anxiety
2008 NIHR Horizon Scanning Centre (NIHR HSC) S-1 for advanced gastric cancer - first line therapy
2008 NIHR Horizon Scanning Centre (NIHR HSC) Pazopanib (GW786034) for advanced and/or metastatic renal cell carcinoma - first/second line
2008 NIHR Horizon Scanning Centre (NIHR HSC) Oncotype DX prognostic and predictive test for early breast cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) TroVax (MVA-5T4) for locally advanced or metastatic renal cell carcinoma – with first line therapy
2008 NIHR Horizon Scanning Centre (NIHR HSC) Methylnaltrexone (MOA-728) for postoperative ileus
2008 NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (MDX-010) for unresectable stage III or IV metastatic melanoma - first or second line treatment
2008 NIHR Horizon Scanning Centre (NIHR HSC) Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Larotaxel for advanced pancreatic cancer: recurrent and/or metastatic - second line
2008 NIHR Horizon Scanning Centre (NIHR HSC) GV1001 for advanced and/or metastatic pancreatic cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) Fingolimod FTY720 for relapsing-remitting and primary progressive multiple sclerosis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus for advanced and/or metastatic renal cell carcinoma - second line
2008 NIHR Horizon Scanning Centre (NIHR HSC) Etanercept (Enbrel) for moderate-to-severe plaque psoriasis in children and adolescents
2008 NIHR Horizon Scanning Centre (NIHR HSC) Dutasteride (Avodart) for prevention of prostate cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) Denosumab for the prevention and treatment of osteoporosis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Decitabine (Dacogen) for myelodysplastic syndrome
2008 NIHR Horizon Scanning Centre (NIHR HSC) Cladribine (Movectro) for multiple sclerosis; relapsing-remitting
2008 NIHR Horizon Scanning Centre (NIHR HSC) Capecitabine (Xeloda) in combination with docetaxel for adjuvant therapy in breast cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) Amibegron (SR-58611) for depression
2008 NIHR Horizon Scanning Centre (NIHR HSC) ABT-874 for moderate-to-severe chronic plaque psoriasis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat (Zolinza) for cutaneous T-cell lymphoma - second line
2008 NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium (Alimta) monotherapy as maintenance therapy for non-small cell lung cancer
2008 Health Intervention and Technology Assessment Program (HITAP) Research for development of an optimal policy strategy for prevention and control of Cervical Cancer in Thailand
2008 Health Intervention and Technology Assessment Program (HITAP) Identifying information regarding effectiveness and cost-effectiveness of policy and strategies reorientation to mitigate the impact of HIV/AIDS in Thailand
2008 Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and safety of autovaccines and bacterial lysates in recurrent respiratory infections]
2008 Andalusian Health Technology Assessment Area (AETSA) [Efficacy of laparoscopy in hepatobiliary pathology]
2008 Andalusian Health Technology Assessment Area (AETSA) [Efficacy of biventricular pacemakers for heart failure]
2008 Andalusian Health Technology Assessment Area (AETSA) [Standards for health technologies appropriateness: Knee arthroscopy. Development of criteria for appropriateness]
2008 Andalusian Health Technology Assessment Area (AETSA) [Economic assessment of mitral valve insufficiency treatment]
2008 Andalusian Health Technology Assessment Area (AETSA) [Diagnostic performance of clinical prediction models for pulmonary embolism]
2008 Andalusian Health Technology Assessment Area (AETSA) [Perfusion MR Imaging in differentiating brain gliomas. Meta-analysis and economic assessment]
2008 Andalusian Health Technology Assessment Area (AETSA) [Standards for health technologies appropriateness: Laparoscopy in acute cholecystitis, choledocholithiasis and cholelithiasis. Development of criteria for appropriateness]
2008 Andalusian Health Technology Assessment Area (AETSA) [Standards for health technologies appropriateness: Knee arthroscopy. Development of criteria for appropriateness]
2008 Andalusian Health Technology Assessment Area (AETSA) [Standards for health technologies appropriateness: Indications of intra-operative ablation in patients with atrial fibrillation. Development of criteria for appropriateness]
2008 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Patient involvement between ideals and reality]
2008 Belgian Health Care Knowledge Centre (KCE) Guidelines for pharmacoeconomic evaluations in Belgium
2008 Belgian Health Care Knowledge Centre (KCE) Video registration of endoscopic surgery: a rapid assessment
2008 Agency for Healthcare Research and Quality (AHRQ) Positron emission tomography for nine cancers (bladder, brain, cervical, kidney, ovarian, pancreatic, prostate, small cell lung, testicular)